Huons introduce asthma treatment with new combination for first time in Korea
Huons(CEO Gi-Ahn Eum), a subsidiary of Huons Global, signed an exclusive distribution license agreement of ‘Zephirus,’ a inhaled capsule for the treatment of asthma, in Korea with Belgian Laboratoires SMB S.A.(SMB) at its headquarters on the 19th.
‘Zephirus,’ a fixed-capacity drug in combinati...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
